Bhubaneswar: National Research Development Corporation (NRDC), CSIR-Central Scientific Instruments Organisation (CSIR-CSIO) and Bhubaneswar-based medtech startup Inflanova Medtech Pvt. Ltd. have signed a tripartite technology licensing agreement for an osteoporosis biomarker screening technology. The agreement, signed at CSIR-CSIO, Chandigarh, covers the transfer of an indigenously developed low-cost, point-of-care paper-strip biosensor for qualitative screening of osteoporosis biomarkers from blood serum.The biosensor requires only a few drops of serum, approximately 10 µL, which are applied to a nanoparticle-labelled immunocomplex test strip. The result can be read visually through a colour change within minutes, without specialised instruments, laboratory infrastructure or advanced technical expertise.Designed as a simple and cost-effective screening tool, the test strip is expected to support health camps and large-scale community screening programmes. It can help identify individuals at risk of osteoporosis and serve as a complementary tool to conventional DEXA and BMD-based assessment, particularly in resource-limited settings.Founded by Shailesh Kumar Samal and Alisha Dash, Inflanova Medtech Pvt Ltd is a Bhubaneswar-based biotechnology company working on vaccines and advanced diagnostics for cardiovascular diseases, chronic inflammation and preventive healthcare. The company focuses on affordable and accessible healthcare solutions for human and veterinary applications through indigenous innovation and strategic collaborations.Osteoporosis remains a major public health concern in India, affecting an estimated 18% to 23% of adults, while osteopenia, or low bone mass, affects about 44% to 50% of the population. The condition is more prevalent among women, especially postmenopausal women, and Indians are known to experience lower bone mineral density and osteoporotic fractures at an earlier age compared with many Western populations. The newly licensed biosensor technology is expected to improve early screening and strengthen preventive healthcare efforts.